Sales rise 315.94% to Rs 70.71 crore
Sales rise 87.91% to Rs 1275.87 crore
Sales decline 10.73% to Rs 1433.62 crore
Sales rise 46.23% to Rs 175292.02 crore
Sales rise 26.78% to Rs 16.95 crore
Dr. Lal PathLabs reported 26.5% fall in consolidated net profit to Rs 61.3 crore in Q4 FY22 compared with the net profit of Rs 83.4 crore in Q4 FY21.
The benchmark indices ended with strong gains on Tuesday amid wide spread buying support. Strong global cues boosted investors sentiment. All the sectoral indices on the NSE ended higher. Metals, oil & gas and media shares rallied. The S&P BSE Sensex jumped 1344.63 points or 2.54% at 54,318.47. The Nifty 50 index gained 417 points or 2.63% at 16,259.30. Reliance Industries (up 4.26%), ITC (up […]
Sales rise 25.73% to Rs 154.09 crore
Sales rise 43.83% to Rs 1328.39 crore
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
